The Indian maker of a cough syrup that was linked to the death of 19 children in Uzbekistan said on December 30 that it had halted production of all medicines after an inspection by the drug regulator. Indian media reported that the inspectors had found deviations from the rules on manufacturing at one of Marion Biotech's units. India's drug regulator and regional authorities had inspected Marion Biotech's facility in Noida, close to Delhi, India's Health Ministry said. To read the original story from Reuters, click here.
Editors' Picks
RFE/RL has been declared an "undesirable organization" by the Russian government.
If you are in Russia or the Russia-controlled parts of Ukraine and hold a Russian passport or are a stateless person residing permanently in Russia or the Russia-controlled parts of Ukraine, please note that you could face fines or imprisonment for sharing, liking, commenting on, or saving our content, or for contacting us.
To find out more, click here.